Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma

NCT04067414 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma
High-grade B-cell Lymphoma
Transformed Lymphoma
Primary Mediastinal Large B Cell Lymphoma

Interventions

BIOLOGICAL: BZ019

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]